Clinical Trials List
2018-12-01 - 2029-05-31
Phase III
Recruiting4
ICD-10E21.0
Primary hyperparathyroidism
ICD-10E21.1
Secondary hyperparathyroidism, not elsewhere classified
ICD-10E21.2
Other hyperparathyroidism
ICD-10E21.3
Hyperparathyroidism, unspecified
ICD-9252.0
Hyperparathyroidism
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Kun-Hua Tu Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yao-jong Yang Division of Pediatrics
- 陳致嘉 Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- GWO-TSANN CHUANG Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8 participants
-
Global
56 participants
